# Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

> **NCT00936624** · PHASE2 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 245 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SOTB07
- **DRUG:** SOTB07
- **DRUG:** placebo
- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT00936624
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936624, "Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00936624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*